NYMOX SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $150,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Nymox Pharmaceutical Corporation - NYMX


NEW ORLEANS, Jan. 19, 2015 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until January 26, 2015 to file lead plaintiff applications in a securities class action lawsuit against Nymox Pharmaceutical Corporation (Nasdaq:NYMX) if they purchased the Company's securities between January 31, 2011 and November 2, 2014, inclusive (the "Class Period"). This action is pending in the United States District Court for the District of New Jersey.

What You May Do

If you purchased shares of Nymox and would like to discuss your legal rights and how this case might affect you and your right to recover for your economic loss, you may, without obligation or cost to you, call toll-free at 1-877-515-1850 or email KSF Managing Partner Lewis Kahn (lewis.kahn@ksfcounsel.com). If you wish to serve as a lead plaintiff in this class action, you must petition the Court by January 26, 2015.

About the Lawsuit

Nymox and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.

On November 2, 2014, Nymox disclosed that the Company's two Phase 3 clinical trials for its proprietary drug NX-1207 for the treatment of benign prostatic hyperplastic (BPH) had to be halted because the drug failed to meet its primary endpoints for efficacy. The following day, Nymox disclosed to the market for the first time, among other things, the difficulties faced in enrolling men for the trials, and the subjective nature of the measurement of the drug's success.

On this news, the price of Nymox's stock plummeted by over 80%.

About Kahn Swick & Foti, LLC

To learn more about KSF, whose partners include the Former Louisiana Attorney General, Charles C. Foti, Jr., and other lawyers with significant experience litigating complex securities class actions nationwide on behalf of both institutional and individual shareholders, you may visit www.ksfcounsel.com.



            

Contact Data